The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations.
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations. J Neurol. 2017 Dec; 264(12):2351-2374.